基本信息
views: 630

Bio
TOR is a major controller of cell growth
TOR (Target of Rapamycin) is a conserved protein kinase that controls a wide range of metabolic processes. More importantly, TOR is a central controller of cell growth that plays a key role in development and ageing. TOR is implicated in many disorders including cancer, cardiovascular disease, diabetes, and obesity. The aim of our research is to elucidate the mechanisms by which TOR is regulated and in turn how it controls its many processes in both health and disease.
Investigating TOR signaling in human tumors
We study TOR signaling and growth control in the yeast Saccharomyces cerevisiae, in mammalian cells, in mice and in human tumors using biochemical, genetic and cell biological approaches. The work with human tumors is a translational research project that relies on close collaborations with clinicians.
New therapeutic strategies
Cell division, growth and death are the most fundamental features of life. Our studies contribute to understanding the important process of cell growth. Understanding mammalian TOR (mTOR) signaling and how it is dysregulated in disease may reveal new therapeutic strategies for a wide variety of disorders.
TOR (Target of Rapamycin) is a conserved protein kinase that controls a wide range of metabolic processes. More importantly, TOR is a central controller of cell growth that plays a key role in development and ageing. TOR is implicated in many disorders including cancer, cardiovascular disease, diabetes, and obesity. The aim of our research is to elucidate the mechanisms by which TOR is regulated and in turn how it controls its many processes in both health and disease.
Investigating TOR signaling in human tumors
We study TOR signaling and growth control in the yeast Saccharomyces cerevisiae, in mammalian cells, in mice and in human tumors using biochemical, genetic and cell biological approaches. The work with human tumors is a translational research project that relies on close collaborations with clinicians.
New therapeutic strategies
Cell division, growth and death are the most fundamental features of life. Our studies contribute to understanding the important process of cell growth. Understanding mammalian TOR (mTOR) signaling and how it is dysregulated in disease may reveal new therapeutic strategies for a wide variety of disorders.
Research Interests
Papers共 1011 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
AMERICAN HEART JOURNAL PLUS CARDIOLOGY RESEARCH AND PRACTICE (2025)
The American Journal of Emergency Medicine (2025)
Naman S. Shetty,Mokshad Gaonkar,Akhil Pampana,Nirav Patel,Alanna C. Morrison,Alexander P. Reiner,April P. Carson,Bing Yu,Bruce M. Psaty,Charles Kooperberg,Diane Fatkin,Eric Boerwinkle,Jerome I. Rotter,Kent D. Taylor,Lifang Hou,Marguerite R. Irvin,Michael E. Hall,Mathew Maurer,Myriam Fornage,Nicole D. Armstrong,Nicole Bart,Parag Goyal,Stephen S. Rich,Ramachandran S. Vasan,Peng Li,Garima Arora,Pankaj Arora
JACC-HEART FAILUREno. 1 (2025): 91-101
Vanessa Wookey,Jeffrey M. Farma,Joshua E. Meyer,Eric A. Ross, Erika Jerome,Tanu Singh, Ryan Romasko, Rosanna Veggeberg,Efrat Dotan,Michael J. Hall,Matthew Philp, Juhi Mittal, Katrina Bynum,Stephanie Greco,Sanjay S. Reddy,Elin R. Sigurdson,Namrata Vijayvergia
Journal of Clinical Oncologyno. 4_suppl (2025): 148-148
Cancersno. 4 (2025)
SUPPORTIVE CARE IN CANCERno. 1 (2024)
openalex(2024)
openalex(2024)
Nadine Tung,Charite Ricker,Hans Messersmith,Judith Balmana,Susan Domchek,Elena Martinez Stoffel,Khaldoun Almhanna,Banu Arun,Yanin Chavarri-Guerra,Stephanie A. Cohen,Deborah Cragun,Katherine D. Crew,Michael J. Hall,Gregory Idos,Ghecemy Lopez,Tuya Pal,Sara Pirzadeh-Miller,Colin Pritchard,Huma Q. Rana,Umang Swami,Gregory A. Vidal
JOURNAL OF CLINICAL ONCOLOGYno. 21 (2024)
Load More
Author Statistics
#Papers: 1013
#Citation: 76331
H-Index: 133
G-Index: 264
Sociability: 8
Diversity: 4
Activity: 410
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn